This platform is currently totally free and created by doctors. 🩺

RxIndia

Loading clinical data...

The most trusted clinical drug reference for Indian healthcare professionals. Providing evidence-based monographs, dosage protocols, and expert guidelines to empower better clinical decisions.

Resources

Full Drug Index
Clinical Guidelines
Classifications
Specialties

Weekly Updates

Stay updated with the latest FDA approvals, drug alerts, and clinical practices.

Verified Clinical Information

"This platform is a clinical reference tool for educational purposes only. It is not a substitute for professional medical judgment, diagnosis, or treatment. Always seek the advice of a qualified physician."

A Medical Intelligence Initiative

About Contact Privacy Terms

Developeredonesolutions

HomeDrug Index

The Drug Registry

Found 5 drugs.

Candesartan

Angiotensin II Receptor Blocker (ARB)

Preferred ARB option in patients intolerant to ACE inhibitors due to dry cough Target dose of 32 mg daily in heart failure has demonstrated mortalit...

View Details

Irbesartan

Angiotensin II Receptor Blocker (ARB)

Diabetic nephropathy: Irbesartan 300 mg/day is specifically evidencebased (IDNT trial) for delaying nephropathy progression in type 2 diabetes with pr...

View Details

Losartan

Angiotensin II Receptor Blocker (ARB)

1. Preferred ARB in diabetic nephropathy — Losartan (at 100 mg/day target dose) has the strongest evidence base for renoprotection in Type 2 DM with p...

View Details

Olmesartan

Angiotensin II Receptor Blocker (ARB)

Olmesartan is uniquely associated with spruelike enteropathy among ARBs — consider this diagnosis in patients with unexplained chronic diarrhoea and w...

View Details

Valsartan

Angiotensin II Receptor Blocker (ARB)

Valsartan is a preferred alternative to ACE inhibitors in patients who develop cough or angioedema with ACEi Oncedaily dosing suffices for hypertens...

View Details

All 5 drugs shown